Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04570020 · ClinicalTrials.gov registry record
Scleral Lens Fitting Using Wide-Field OCT
A clinical trial of Keratoconus and Irregular; Contour of Cornea, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 258
- Enrollment target
- 1
- Study location
NCT04570020: Recruiting study of Keratoconus and Irregular; Contour of Cornea, sponsored by Oregon Health and Science University.
NCT04570020 is a study of Keratoconus and Irregular; Contour of Cornea that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 258 participants, below the 1,168-participant average among 21 other Keratoconus trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04570020, a study of Keratoconus and Irregular; Contour of Cornea, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 258 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if OCT technology can optimize scleral contact lens fittings. Subjects with keratoconus, post-penetrating keratoplasty (PK), post-LASIK ectasia, post-radial keratotomy (RK), or a variety of anterior surface disorders requiring scleral lens fittings will be considered for enrollment. For each study eye, a clinically-selected scleral lens fit will be compared against an OCT-selected lens fit. The quality of each lens fit will be determined by flourescein exam at the slit lamp. Apical clearance, limbal clearance, conjunctival compression, and lens edge lift will be assessed. A lens that satisfies all four criteria will be considered satisfactory.
Primary Outcome
Apical clearance of each lens (whether clinically-selected or OCT-selected) will be graded as "acceptable," "too high," or "too low."
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University, Casey Eye Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2028-12 |
What NCT04570020 shows while recruiting
NCT04570020 is an observational study that tracks outcomes without assigning an intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,168-participant average among 21 other Keratoconus trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Keratoconus appearing as the primary indexed condition, and to 0 interventions.
NCT04570020 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04570020 about?
NCT04570020 is a clinical study titled "Scleral Lens Fitting Using Wide-Field OCT". The purpose of this study is to see if OCT technology can optimize scleral contact lens fittings. Subjects with keratoconus, post-penetrating keratoplasty (PK), post-LASIK ectasia, post-radial keratotomy (RK), or a variety of anterior surface disorders requiring scleral lens fittings will be conside...
What is the current status of trial NCT04570020?
This trial is currently recruiting. The enrollment target is 258 participants. The study started on 2020-09-23. Estimated completion is 2028-12.
What conditions does trial NCT04570020 study?
This clinical trial studies the following conditions: Keratoconus, Irregular; Contour of Cornea.
Who is sponsoring clinical trial NCT04570020?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04570020 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04570020's enrollment target sits among peer trials
258 9th of 21 higher than 13 of 21 other Keratoconus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI